tm logo
X-ZONE
Live/Registered
REGISTERED

on 06 Dec 2022

Last Applicant/ Owned by

56 Bush Road,

Waiatarua Auckland

NZ

0604

Serial Number

79297142 filed on 09th Jun 2020

Registration Number

6914777 registered on 06th Dec 2022

in the Principal Register

Correspondent Address

Jeff Goehring

Jeff Goehring

901 N. Glebe Road, 11th Floor

Arlington VA 22203

Filing Basis

No Filing Basis

Disclaimer

NO DATA

X-ZONE

Muscle pain relief and medicated performance gels, creams, topical sprays and roll ons; medicinal preparations for human use all in the form of balm; plant extracts for pharmaceutical purposes; medicinal herbs; medicinal oils; cannabis related products, namely, oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis or derivatives of cannabis, namely, resins an Read More

Classification Information


Class [005]
Pharmaceutical Products


Muscle pain relief and medicated performance gels, creams, topical sprays and roll ons; medicinal preparations for human use all in the form of balm; plant extracts for pharmaceutical purposes; medicinal herbs; medicinal oils; cannabis related products, namely, oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis or derivatives of cannabis, namely, resins and oils for medical or therapeutic purposes, each for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; nutraceuticals and herbs for medicinal purposes each containing cannabis and derivatives of cannabis, namely, resins and oils, for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; analgesics; topical analgesic creams; antipyretic analgesics; anti-inflammatory analgesic plasters; pain relieving creams; pain relief preparations; multi-purpose medicated analgesic balms; effervescent analgesic pharmaceutical preparations; antiseptics; bath salts for medical purposes; bath preparations for medical purposes; herbal teas for medicinal purposes; medicated capillary lotions; medicated soap; medicated shampoos; medicinal tea; mineral waters for medical purposes; tissues impregnated with pharmaceutical skin lotions; mouthwashes for medical purposes; tinctures for medical purposes; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medical purposes for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils; topical skin creams and gels, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations for medical purposes; oral sprays containing cannabis for medical purposes for use as central nervous system stimulants; topical creams, lotions, balms, oils, sprays, and transdermal patches for the relief of pain; medicinal, herbal and botanical preparations and supplements all for medical purposes in the form of oil extracts, oils, extracts, tinctures, resins, waxes, hashes, pastes, balms, salves, concentrates, lotions, sprays, ointments, pastes, tonics, liquids, powders, teas, coffees, beverages, topical skin creams, lotions and gels, pills, tablets, capsules, suppositories, skin patches, sublingual doses, and mucous membrane doses, sprays and liquids, transdermal patches and oral sprays, for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; insect repellents, insecticides and insect repellents; anti-fungal creams for medical use; fungicides; after-sun creams for medical use; medicated sun tanning preparations; aloe vera gel for therapeutic purposes; anti-bacterial throat sprays and mouth washes; medicated hair care preparations and lotions; decongestants; decongestant nasal sprays; medicated body and beauty care preparations, namely, preparations in the form of creams, gels and lotions, all for the care of dry skin; dermatologicals for treatment of eczema, psoriasis and dermatological conditions; medicated bath and shower additives; medicated preparations for the care and cleaning of hair; medicated preparations for aged skin, namely, anti-aging creams and anti-aging serums; acne and skin blemish treatment medications; anti-itch creams and ointments; pharmaceutical preparations for the relief of insect bites; preparations for the treatment of burns; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; all of the aforementioned goods containing cannabis ingredients being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and no cannabidiol (CBD)

Mark Details


Serial Number

No 79297142

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 7913-0020

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Apr 2023FINAL DECISION TRANSACTION PROCESSED BY IB
23rd Mar 2023FINAL DISPOSITION NOTICE SENT TO IB
23rd Mar 2023FINAL DISPOSITION PROCESSED
06th Mar 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06th Dec 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
06th Dec 2022REGISTERED-PRINCIPAL REGISTER
02th Oct 2022NOTIFICATION PROCESSED BY IB
20th Sep 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Sep 2022PUBLISHED FOR OPPOSITION
07th Sep 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB